Prospective registry study to record the diagnosis and treatment of diabetic sensorimotor polyneuropathy
Recruiting
- Conditions
- G63.2Diabetic polyneuropathy
- Registration Number
- DRKS00017845
- Lead Sponsor
- WÖRWAG Pharma GmbH & Co. KG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1100
Inclusion Criteria
• Patients with diagnosed polyneuropathy in diabetes mellitus or prediabetes.
• Patients who are present at the time of enrollment at diagnosis or follow up on polyneuropathy.
• Written consent to study participation is available.
• Age = 18 years.
Exclusion Criteria
• Neuropathies that are, in the opinion of the physician,non-diabetes related.
• Patients with confirmed other painful illnesses that focus on non-neuropathic complaints (eg, spinal disorders, orthopedic or rheumatologic diseases).
• Patients with existing consumptive diseases or in a palliative situation.
• Participation or planned participation in an interventional study on neuropathy or neuropathic pain at the time of inclusion.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Documentation and presentation of diagnostics and therapy practice with DSP
- Secondary Outcome Measures
Name Time Method a. Comparison of treatment success of different therapeutic approaches in DSPN.<br>b. Comparison of the side-effect profile and tolerability in different therapeutic approaches in DSPN.<br>c. Comparison of disease progression in different therapeutic approaches in DSPN.<br>d. Comparison of quality of life in different therapeutic approaches in DSPN.<br>e. Identification of problems and confounding factors related to DSPN therapy.